Zobrazeno 1 - 10
of 204
pro vyhledávání: '"J.-P. Jouet"'
Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT
Autor:
Salut Brunet, Alois Gratwohl, Zwaan Fe, Mauricette Michallet, Witz F, Bourdeau He, L. Molina, Corront B, Moine A, Charles Dauriac, J P Jouet, J Soler, William Arcese, Noel-Jean Milpied
Publikováno v:
Leukemialymphoma. 5
Allogeneic bone marrow transplantation (BMT) was performed in 17 patients with chronic lymphocytic leukemia (CLL): 15 resistant and 2 untreated forms; 12 males and 5 females with a mean age of 40 years (32-49). The conditioning regimen and graft vers
Autor:
M. Cauli, J.-P. Jouet
Publikováno v:
Éthique & Santé. 7:31-35
Resume Sensible, la greffe d’organe est soumise a une logique d’appropriation pour celui qui l’accueille et fait l’objet de commentaires emotionnels, culturels et symboliques. L’article s’attache a analyser ce processus et explore le pass
Autor:
S. Thiant, Leonardo Magro, J P Jouet, Jean-Paul Dessaint, Jacques Trauet, Valérie Coiteux, Myriam Labalette, Ibrahim Yakoub-Agha
Publikováno v:
Bone Marrow Transplantation. 45:1546-1552
T-cell reconstitution after allo-SCT initially depends on homeostatic peripheral expansion of donor T cells, the level of which may promote the differentiation of alloreactive and tumor-reactive effectors. IL-7 and IL-15 exert their effect as key hom
Publikováno v:
Médecine Nucléaire. 33:491-498
Resume La radio-immunotherapie par Zevalin® est indiquee en traitement du lymphome folliculaire en rechute ou refractaire au rituximab depuis 2004. Cette indication a ete etendue en 2008 au traitement de consolidation du lymphome folliculaire en pre
Autor:
Ibrahim Yakoub-Agha, Leonardo Magro, Bénédicte Bruno, Valérie Coiteux, Benoit Catteau, J P Jouet
Publikováno v:
Bone Marrow Transplantation. 42:757-760
Treatment of sclerodermatous chronic GVHD (cGVHD) remains disappointing. Imatinib mesylate enables selective, dual inhibition of the transforming growth factor beta (TGFbeta) and PDGF pathways. Recently, the drug's effects on fibroblasts have been re
Autor:
Francis Bauters, Boulanger-Villard F, C. Grutzmacher, Ibrahim Yakoub-Agha, Jean-Baptiste Micol, Myriam Labalette, Pasquine Saule, Jean Paul Dessaint, Stéphane Depil, J P Jouet
Publikováno v:
Leukemia. 20:1557-1565
CC-chemokine receptor 7 (CCR7), a chemokine receptor required for transmigration into lymphoid organs, is only expressed by naive and central memory T cells. T cells with a capacity of homing into lymphoid organs can initiate acute graft-versus-host
Publikováno v:
EMC - Hématologie. 1:1-15
Autor:
Cécile Borel, Noel Milpied, Sophie Alain, C. Giraud, I. Yakoub-Agha, Karin Bilger, Serge Alfandari, Nathalie Dhedin, Anne Thiebaut, J.-P. Jouet, Remy Dulery, E. Willems, J.-L. Beaumont, Anny Dewilde
Publikováno v:
Pathologie Biologie. 61:155-157
Resume Dans une demarche qui vise a uniformiser la prise en charge des malades faisant l’objet d’une allogreffe de cellules souches hematopoietiques, la societe francaise de greffe de moelle et de therapie cellulaire (SFGM-TC) a organise les troi
Autor:
Mauricette Michallet, Emmanuelle Polge, Josy Reiffers, Myriam Labopin, J P Jouet, Didier Blaise, Norbert-Claude Gorin, Catherine Cordonnier, Francesco Frassoni, Bernard Rio, Noel-Jean Milpied
Publikováno v:
Leukemia. 17:1596-1599
In 1402 patients allografted in Europe during the period 1990-2000 with an HLA-identical sibling in first remission (CR1), the median interval from CR1 to allotransplant (96 days) was a major prognostic factor, patients transplanted earlier having a
Autor:
André Baruchel, Odile Blanchet, J. H. Bourhis, C. Faucher, Helene Esperou, M Kuentz, Pierre Bordigoni, Noel-Jean Milpied, J.Y. Cahn, Hervé Dombret, M-L Tanguy, J P Vernant, Jean Gabert, Norbert Ifrah, J M Cayuela, J P Jouet, Marie-Cécile Michallet, J-M Boiron
Publikováno v:
Bone Marrow Transplantation. 31:909-918
Philadelphia chromosome (Ph) acute lymphoblastic leukemia-positive (ALL) is a subgroup of ALL with a poor prognosis. We sought to evaluate the results of allogeneic hematopoietic stem cell transplantation (HSCT) in this situation. From 1992 to 2000,